Another recent study evaluated associations between FGF23 and different outcomes, including all-cause mortality, recurrent MI, and hospitalization for HF, in participants of the TOTAL-AMI (Tailoring of treatment in all comers with acute myocardial infarction) project [37]. This evidence concerns the gene FGF23 and myocardial infarction.